Last-resort virus therapy takes on untreatable hip infection
NCT ID NCT07461337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether specially designed viruses (bacteriophages) can eliminate a persistent bacterial infection in a hip replacement joint. One adult who has failed all standard surgeries and antibiotics will receive the viruses directly into the joint and through an IV for two weeks. The goal is to clear the infection and avoid further complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIOPHAGE THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foothills Medical Centre, University of Calgary
Calgary, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smarter surgery and antibiotic combo cure joint infections for good?
- Biobank aims to unlock secrets of phage therapy against superbugs
- Viruses vs. superbugs: new hope for skin infections?
- Desperate times: phage cocktail takes on Drug-Resistant lung bug
- Could a special suture cut infection risk after joint replacement?
- New drug could save infected joint implants, avoid major surgery